Anodyne| Piperine | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 285.34 g/mol [1] |
| Melting point | 129 °C [1] |
| Boiling point | 498.00 to 499.00 °C. @ 760.00 mm Hg [1] |
| Solubility | 0.04 mg/mL at 18 °C [1] |
| Predicted LogP | 3.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H19NO3 [1] |
| IUPAC name | (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one [1] |
| SMILES | C1CCN(CC1)C(=O)/C=C/C=C/C2=CC3=C(C=C2)OCO3 [1] |
| InChI | InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+ [1] |
| InChIKey | MXXWOMGUGJBKIW-YPCIICBESA-N [1] |
| Toxicity [] | |
|---|---|
| LD50 | Hamster: - intraperitoneal: 105 mg/kg Rat: - intraperitoneal: 34 mg/kg - oral: 514 mg/kg Mouse: - oral: 330 mg/kg - intraperitoneal: 43 mg/kg - subcutaneous: 200 mg/kg - intravenous: 15100 μg/kg - intramuscular: 400 μg/kg - intravenous: 71 mg/kg |
Piperine
Piperine (also known as 1-Piperoylpiperidine, Piperin, Bioperine, Piperoylpiperidine, FEMA No. 2909, piperidine, 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one, N-[(E,E)-Piperoyl]piperidine, 1-Piperoyl-piperidine or Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)-) is a
Chemistry
Stereochemistry []
Piperine is a achiral mixture
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 638024, Piperine. Accessed September 12, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/638024
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Piperine. UNII: U71XL721QK. Global Substance Registration System. Accessed September 12, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/U71XL721QK